LGVN - Longeveron Inc.
IEX Last Trade
1.82
0.010 0.549%
Share volume: 1,061
Last Updated: Thu 26 Dec 2024 08:29:32 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.11%
PREVIOUS CLOSE
CHG
CHG%
$1.81
0.01
0.55%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-12 | 2022-11-14 | 2023-03-14 | 2023-05-12 | 2023-08-11 | 2023-11-09 | 2024-02-27 | 2024-05-14 | |
| Total revenue | 466.000 K | 265.000 K | 121.000 K | 279.000 K | 217.000 K | 150.000 K | 63.000 K | 548.000 K | |
| Cost of revenue | 306.000 K | 173.000 K | 176.000 K | 203.000 K | 124.000 K | 96.000 K | 65.000 K | 219.000 K | |
| Gross profit | 160.000 K | 92.000 K | -55.000 K | 76.000 K | 93.000 K | 54.000 K | -2.000 K | 329.000 K | |
| -42.50% | -159.78% | 238.18% | 22.37% | -41.94% | -103.70% | 16,550.00% | |||
| Operating expenses | 4.381 M | 5.279 M | 5.186 M | 4.792 M | 5.805 M | 5.215 M | 5.438 M | 4.419 M | |
| Selling general and admin | 2.661 M | 2.319 M | 1.923 M | 2.012 M | 3.518 M | 3.372 M | 3.282 M | 2.200 M | |
| Research and development | 1.720 M | 2.960 M | 3.263 M | 2.780 M | 2.287 M | 1.843 M | 2.156 M | 2.219 M | |
| Total expenses | 4.687 M | 5.452 M | 5.362 M | 4.995 M | 5.929 M | 5.311 M | 5.503 M | 4.638 M | |
| 16.32% | -1.65% | -6.84% | 18.70% | -10.42% | 3.62% | -15.72% | |||
| Operating income | -4.221 M | -5.187 M | -5.241 M | -4.716 M | -5.712 M | -5.161 M | -5.440 M | -4.090 M | |
| Ebit | -4.221 M | -5.187 M | -5.241 M | -4.716 M | -5.712 M | -5.161 M | -5.440 M | -4.090 M | |
| Pretax income | -5.624 M | -5.244 M | -4.457 M | -4.647 M | -5.632 M | -5.106 M | -6.028 M | -4.058 M | |
| -6.76% | -15.01% | 4.26% | 21.20% | -9.34% | 18.06% | -32.68% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | -5.624 M | -5.244 M | -4.457 M | -4.647 M | -5.632 M | -5.904 M | -6.028 M | -4.058 M | |
| 6.76% | 15.01% | -4.26% | -21.20% | -4.83% | -2.10% | 32.68% | |||
| Net income | -5.624 M | -5.244 M | -4.457 M | -4.647 M | -5.632 M | -5.904 M | -6.028 M | -4.058 M | |
| 6.76% | 15.01% | -4.26% | -21.20% | -4.83% | -2.10% | 32.68% |